NEJM 4 2026 Discontinuation of Beta-Blocker Therapy after Myocardial Infarction.

This study evaluates whether patients with stable heart function can safely stop taking long-term beta-blocker therapy after recovering from a heart attack. Researchers conducted a clinical trial to determine if discontinuing the medication was just as safe as continuing it for those who had already been on the treatment for at least one year. The findings revealed that stopping the drug did not increase the risk of death, repeat heart attacks, or hospitalization, effectively meeting the criteria for noninferiority. Ultimately, the results suggest that for certain low-risk patients, continuing these prescriptions indefinitely may no longer be necessary in the context of modern medical care.